David Wood

David Wood PhD


Executive Summary

David Wood is a partner and patent agent in our Calgary office. David practices intellectual property and regulatory law. David is co-chair of the Borden Ladner Gervais Cannabis Industry Focus Group and his regulatory practice is specific to the Canadian cannabis industry.

David has advised federal cannabis licensees, pre-license entities, technology companies, and other domestic and foreign participants in the Canadian cannabis industry in relation to the Cannabis Act and its regulations, including the Cannabis Regulations and the Industrial Hemp Regulations (the "IHR").

David’s intellectual property practice and experience includes:​​

  • drafting and prosecuting patent applications;
  • assessing patentability of technology, validity of patents, and infringement of patents, and other patent-related due diligence;
  • multi-jurisdictional patent portfolio management; and
  • patent litigation.

David has experience with chemical, biochemical, information, and mechanical technologies relating to cannabis, medical devices, imaging, oil and gas, and other industries.

During his doctoral work, David characterized a complex between DNA and metal ions using a number of biochemical and biophysical techniques, including surface plasmon resonance spectroscopy, quenching of DNA-tethered fluorophores, and ethidium-based fluorescence assays. David’s education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian cannabis industry in relation to both intellectual property and regulatory law.

In addition to his technical background, David’s understanding of the federal Cannabis Act,Cannabis Regulations, the IHR and other applicable law, and the Alberta Gaming, Liquor and Cannabis Act, and his familiarity with the Canadian cannabis industry and its participants, each add value when advising domestic and foreign clients in relation to developing or licensing technology related to the Canadian cannabis industry. He has presented on the topic many times and in many contexts, and is able to effectively help audiences understand the industry.

Representative Work

  • Advising an international pharmaceutical company in relation to cannabis supply, regulatory compliance and dosage forms
  • Advising a national pharmacy chain in relation to cannabis supply, regulatory compliance and new product categories
  • Advising a natural health products company in relation to licensing for processing and cultivation and intellectual property
  • Assisting with the going-public transaction for Brassneck Capital Corp. through reverse takeover by National Access Cannabis Corp
  • Providing ongoing regulatory advice to federal cannabis licensees and to entities applying for licenses under the Cannabis Regulations
  • Advising federal cannabis licensees, provincial retail licensees, cannabis accessories vendors, clinics and other entities in relation to promotional activity regulated by the Cannabis Act and provincial legislation
  • Advising on, drafting and negotiating multiple cannabis supply agreements between cultivators and processors
  • Advising on transaction of hemp flowers between Industrial Hemp Regulations licensees and cannabis processors
  • Advising food companies in relation to positioning for sale of edibles, including foods and beverages
  • Advising multiple entities of varying sizes on obtaining retail sales licenses or permits in Alberta including the appeal process, and through collaboration with other professionals, British Columbia, Ontario, and Saskatchewan
  • Drafting website terms and conditions and privacy policy, and advising on online promotional activity, for domestic and foreign federal cannabis licensees, provincially licensed retailers, social media sites, and other industry participants
  • Advising multiple technology companies (domestic and foreign), including licensed producers, licensed dealers and applicants, in relation to:
    • Scope of activities under Cannabis Regulations licences, and Marihuana Medical Access Regulations licences extended by R v. Allard
    • Intellectual property licensing
    • Patent rights, including drafting and filing patent applications in relation to biotechnology and dosage forms
    • Plant breeders’ rights
    • Trade secrets
  • Advising assisted living facilities in relation to the scope of practice of nurses outside of hospitals, and in relation to adult use policies
  • Working with professionals in BLG's corporate and immigration groups to move a skilled individual into Canada to work in the cannabis industry
  • Advising federal cannabis licensees and other entities on the scope of wares and services that may be included in trademark applications to position for product diversification
  • Engaging the Government of Canada on behalf of licensed producers and licensed dealers to prepare submissions on regulations under the Cannabis Act and the Excise Act

Publications & Presentations